Singh, C., Wadhera, S., Yanamandra, U., Karunakaran, P., Jindal, N., Kumar, S. R., . . . Lad, D. (2022). High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. Acta Oncologica, 61(12), 1512. https://doi.org/10.1080/0284186X.2022.2162347
Chicago Style (17th ed.) CitationSingh, Charanpreet, et al. "High-dose Hydroxyurea with Differentiating Agents for Treating Ultra-high-risk Acute Promyelocytic Leukemia in Resource-challenged Settings." Acta Oncologica 61, no. 12 (2022): 1512. https://doi.org/10.1080/0284186X.2022.2162347.
MLA (9th ed.) CitationSingh, Charanpreet, et al. "High-dose Hydroxyurea with Differentiating Agents for Treating Ultra-high-risk Acute Promyelocytic Leukemia in Resource-challenged Settings." Acta Oncologica, vol. 61, no. 12, 2022, p. 1512, https://doi.org/10.1080/0284186X.2022.2162347.